Main > RHEUMATOLOGY>RHEUMATOID ARTHRITIS > Treatment > Tumor Necrosis Factor Inhibitors > Co.: USA. C (MAb/Phase III/Patents)

---

Co.: USA. C (MAb/Phase III/Patents)'s subsections
Company
Generic Name: GolimuMAb
Marketing>Non-USA
Marketing>USA
Status>EU>MAA Requested
UpDate: 03.18.08. (PR)

Co.: USA. C (MAb/Phase III/Patents)'s products
This section has no products